MedTrace Logo

Children With HIV and Asthma (CHIVAS)

NCT01644370 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-02-22

No results posted yet for this study

Summary

To explore allergen-specific effector and regulatory T cell response in HIV-infected children before and after HAART initiation

Conditions

  • T Cell Response to Asthma in HIV-infected Patients Before and After Starting Treatment

Interventions

DRUG

HAART

as per Thai HIV Treatment guidelines

Sponsors & Collaborators

  • Chulalongkorn University

    collaborator OTHER

  • National Health Security Office, Thailand

    collaborator OTHER

  • The HIV Netherlands Australia Thailand Research Collaboration

    lead OTHER

Principal Investigators

  • Praphan Phanuphak, MD, PhD · The HIV Netherlands Australia Thailand Research Collaboration

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2014-07-31
Completion
2015-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01644370 on ClinicalTrials.gov